Insights & Analysis
There’s one constant in healthcare: change. Count on us to break down the trends so you can stay up to date. Follow our take on each piece of this deep, intertwined, and often perplexing industry to find opportunities and practical approaches to move healthcare forward.
Featured Content
Premium Content
Premium Content
Avalere’s Take on the ACA Market Stabilization Rule
Today, the Trump administration released a proposed rule for market stabilization of the Affordable Care Act (ACA).
Initial Analysis of ICER’s Value Framework Update
Today, the Institute for Clinical and Economic Review (ICER) released an updated version of its Value Assessment Framework.
Advancing Oncology Care Quality in the Era of Immuno-Oncology and Other Evolving Treatments
In June 2016, Avalere in collaboration with the American Society of Clinical Oncology, Cancer Support Community, Community Oncology Alliance, and Patient Advocate Foundation, and with support from Bristol-Myers Squibb, brought together a variety of healthcare stakeholders in a national Dialogue to discuss challenges and opportunities surrounding the advancement of quality in cancer care.
Promoting Shared Decision Making Around Costs to Improve Value
Avalere and the Robert Wood Johnson Foundation Launch Eight Grants to Improve Cost-of-Care Conversations Between Patients and Clinicians.
Avalere Releases Healthcare Industry Trends Report for 2017
This year will be the start of major environmental changes for the healthcare industry following a shift in the balance of power in Washington, DC, and the states.
Christie Teigland, PhD, Appointed to PQA Panel
Avalere Vice President, Christie Teigland, PhD, was recently appointed to the Pharmacy Quality Alliance’s (PQA) Quality Metrics Expert Panel (QMEP) for a three-year term effective January 1, 2017.
Avalere Analysis on Final EPM Bundle Rule
Today, the Centers for Medicare & Medicaid Services took another step in shifting Medicare to a value-based payment model that rewards hospitals for delivering better care at a lower cost.
Overview of Appropriate Use Criteria for Treating Knee Osteoarthritis
Earlier this year, Avalere led a work group of rheumatology, orthopedic surgery, psychiatry, sports medicine, and primary care clinicians to develop appropriate use criteria for the use of hyaluronic acid (HA) in the treatment of knee osteoarthritis (OA).
What You Need to Know About Today’s Cures Vote
Today, the House will vote on the updated version of the 21st Century Cures Act, H.R.34.
Deconstructing the Path to Innovation Adoption
During the last week of October, Avalere invited a select group of innovators to breakfasts in Los Angeles and San Francisco to discuss elements of successful adoption of innovative technologies and models of care.
Avalere Research Recently Published in Home Healthcare Journal
Avalere recently partnered with the Alliance for Home Health Quality and Innovation (AHHQI) to explore the topic of the future of home health care.
Releasing the Draft Avalere/FasterCures Patient-Perspective Value Framework (PPVF) for Public Input
Avalere and FasterCures released the first deliverable of the Patient-Perspective Value Framework (PPVF) Initiative at the annual Partnering for Cures Conference.
Election 2016 Results and Potential Implications
In addition to Donald Trump's presidential win earlier this week, Republicans also won big in the House and Senate.
Rates of Hospital Acquisition of Physician Practices Have Accelerated Dramatically in Rural Areas
Avalere recently partnered with the Physicians Advocacy Institute to examine trends in physician employment and practice ownership by hospitals and health systems from 2012 to 2015.
Avalere’s Research Team to Present Comparative Effectiveness Research at Cystic Fibrosis Conference
Results from a new Avalere study will be presented Thursday, October 27, at the 30th Annual North American Cystic Fibrosis Conference in Orlando, Florida.
Stakeholders Encourage More Patient Involvement in Value Assessment Process
This summer, the Institute for Clinical and Economic Review (ICER) opened a national call for suggestions on how to improve its value assessment framework. In response, ICER received over 50 comments. On October 4, ICER made 46 of those comment letters public.
Presidential Debate #2: Will They or Won’t They Discuss Healthcare?
While we can't make any promises as to whether or not Clinton or Trump will bring up healthcare in Sunday's town hall, the odds of it happening are looking better.
Everything You Need to Know About Kaine and Pence for the VP Debates
In preparation for tonight's vice presidential debates, we thought that we'd take a look at both candidates' health policy positions in addition to Exchange and Part D data for Virginia and Indiana.
Avalere Analysis on Recently Released 2017 Medicare Advantage Landscape Files
The Centers for Medicare & Medicaid Services (CMS) just released the annual Landscape Files containing data on plan participation, beneficiary premiums, and benefit designs for the 2017 Part D and Medicare Advantage (MA) markets. Avalere offers the following observations on key trends in the MA and Part D programs that are likely to influence the 2017 market.
What Will the Future of Home Health Look Like?
Recently, Avalere partnered with the Alliance for Home Health Quality and Innovation to better understand how home healthcare is currently being used and how it will be used in the future for older Americans and Americans with disabilities.